Amendment SSA1-SB288

SB288-SSA1,4,13 (c) A cancer clinical trial under par. (b) must satisfy all of the following criteria:

SB288-SSA1,4,15 1. A purpose of the trial is to test whether the intervention potentially improves the trial participant's health outcomes.

SB288-SSA1,4,17 2. The treatment provided as part of the trial is given with the intention of improving the trial participant's health outcomes.

SB288-SSA1,4,19 3. The trial has therapeutic intent and is not designed exclusively to test toxicity or disease pathophysiology.

SB288-SSA1,4,20 4. The trial does one of the following:

SB288-SSA1,4,22 a. Tests how to administer a health care service, item, or drug for the treatment of cancer.

SB288-SSA1,4,24 b. Tests responses to a health care service, item, or drug for the treatment of cancer.

SB288-SSA1,5,3 c. Compares the effectiveness of health care services, items, or drugs for the treatment of cancer with that of other health care services, items, or drugs for the treatment of cancer.

SB288-SSA1,5,5 d. Studies new uses of health care services, items, or drugs for the treatment of cancer.

SB288-SSA1,5,6 5. The trial is approved by one of the following:

SB288-SSA1,5,8 a. A National Institute of Health, or one of its cooperative groups or centers, under the federal department of health and human services.

SB288-SSA1,5,9 b. The federal food and drug administration.

SB288-SSA1,5,10 c. The federal department of defense.

SB288-SSA1,5,11 d. The federal department of veterans affairs.

SB288-SSA1,5,13 (d) 1. The coverage that may not be excluded under this subsection shall apply to all phases of a cancer clinical trial.

SB288-SSA1,5,18 2. The coverage that may not be excluded under this subsection is subject to all terms, conditions, restrictions, exclusions, and limitations that apply to any other coverage under the policy, plan, or contract, including the treatment under the policy, plan, or contract of services performed by participating and nonparticipating providers.

SB288-SSA1,5,21 (e) 1. Nothing in the subsection requires a policy, plan, or contract to offer; or prohibits a policy, plan, or contract from offering; cancer clinical trial services by a participating provider.

SB288-SSA1,5,25 2. Nothing in this subsection requires services that are performed in a cancer clinical trial by a nonparticipating provider of a policy, plan, or contract to be reimbursed at the same rate as a participating provider of the policy, plan, or contract.

SB288-SSA1, s. 11 Section 11. Initial applicability.

SB288-SSA1,6,2 (1) This act first applies to all of the following:

SB288-SSA1,6,5 (a) Except as provided in paragraphs (b) and (c), disability insurance policies that are issued or renewed, and self-insured health plans that are established, extended, modified, or renewed, on the effective date of this paragraph.

SB288-SSA1,6,8 (b) Disability insurance policies covering employees who are affected by a collective bargaining agreement containing provisions inconsistent with this act that are issued or renewed on the earlier of the following:

SB288-SSA1,6,9 1. The day on which the collective bargaining agreement expires.

SB288-SSA1,6,11 2. The day on which the collective bargaining agreement is extended, modified, or renewed.

SB288-SSA1,6,14 (c) Self-insured health plans covering employees who are affected by a collective bargaining agreement containing provisions inconsistent with this act that are established, extended, modified, or renewed on the earlier of the following:

SB288-SSA1,6,15 1. The day on which the collective bargaining agreement expires.

SB288-SSA1,6,17 2. The day on which the collective bargaining agreement is extended, modified, or renewed.

SB288-SSA1, s. 12 Section 12. Effective date.

SB288-SSA1,6,20 (1) This act takes effect on the first day of the 7th month beginning after publication.

SB288-SSA1,6,21 (End)